News & Perspective

Oct 12, 2016

Oct 12, 2016
ZMapp Ebola drug research

Trial offers mixed view of Ebola drug ZMapp

"I would view the results . . . in an optimistic light," said lead author Richard Davey after the drug showed more than 90% efficacy.

Aug 16, 2016

Aug 16, 2016

News Scan for Aug 16, 2016

Malaria may boost Ebola survival
Scallop hepatitis A source
Inhaled vs injectable flu vaccine
Camels and human cold virus
Venezuela malaria spike

Jul 05, 2016

Jul 05, 2016

News Scan for Jul 05, 2016

Ebola survivor drug study
MERS linked to camels
Reduced antibiotics
HPV and cervical abnormalities

Apr 20, 2016

Apr 20, 2016
Ebola virus

Trial suggests potential for sequential use of 2 Ebola vaccines

Meanwhile, a different study met with disappointing results for an experimental Ebola drug in the Sierra Leone trial.

Feb 25, 2016

Feb 25, 2016
Ebola survivor in Liberia

Studies on Ebola survivors show range of complications

Findings include neurologic problems and a potential for virus survival in semen for 18 months.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»